Pharma giant in India buys Concert Pharmaceuticals in $576M deal

An Indian drugmaker will buy Lexington's Concert Pharmaceuticals (NASDAQ: CNCE) in a cash deal valued at an initial $576 million, the two companies announced Thursday.

Previous Fair Oaks Water District corp yard redevelopment concerns neighboring property owners
Next Fremont cancer test business Personalis to cut staff by one-third